韩国2012-2017年头孢菌素耐药淋球菌嵌合penA等位基因的出现与传播
韩国淋球菌耐药监测有限。2012-2017年,全国淋球菌阳性NAAT标本中嵌合penA等位基因比例从1.1%升至23.9%。嵌合penA菌株起源于首尔和釜山枢纽后播散全国,以penA-10.001为主(572株,94.7%),并检出penA-34.001和penA-60.001。
要点
- 韩国嵌合penA淋球菌比例6年间由1.1%升至23.9%。
- penA-10.001占572株(94.7%),与头孢克肟耐药相关。
- 建议从淋球菌阳性NAAT标本开展分子耐药预测。
核心结论
- 韩国嵌合penA淋球菌在2012-2017年间出现并全国播散,与广谱头孢菌素敏感性下降和耐药相关。
研究设计与样本
- 研究分析了2012年至2017年韩国全国淋球菌阳性核酸扩增检测(NAAT)标本中嵌合penA等位基因的分布与变化。
主要发现
- 嵌合penA等位基因比例从2012年1.1%升至2017年23.9%。
- 嵌合penA菌株起源于首尔(京畿道)和釜山(庆尚南道)国际枢纽后播散全国。
- 最常见为嵌合penA-10.001(n=572株,94.7%),与头孢克肟耐药相关。
- 检出嵌合penA-34.001和penA-60.001,与多重耐药淋球菌及头孢克肟和头孢曲松耐药传播相关。
临床怎么用
- 在韩国及国际上,应从淋球菌阳性NAAT标本实施分子耐药预测。
局限性
- 韩国淋球菌抗菌药物耐药监测极为有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In South Korea, surveillance of antimicrobial drug resistance in Neisseria gonorrhoeae is extremely limited. We describe the emergence and subsequent national spread of N. gonorrhoeae strains with mosaic penA alleles associated with decreased susceptibility and resistance to extended-spectrum cephalosporins. From 2012 through 2017, the proportion of mosaic penA alleles in gonococcal-positive nucleic acid amplification test (NAAT) specimens across South Korea increased from 1.1% to 23.9%. Gonococcal strains with mosaic penA alleles emerged in the international hubs of Seoul in Gyeonggi Province and Busan in South Gyeongsang Province and subsequently spread across South Korea. Most common was mosaic penA-10.001 (n = 572 isolates; 94.7%), which is associated with cefixime resistance. We also identified mosaic penA-34.001 and penA-60.001, both of which are associated with multidrug-resistant gonococcal strains and spread of cefixime and ceftriaxone resistance. Implementation of molecular resistance prediction from N. gonorrhoeae-positive nucleic acid amplification test specimens is imperative in South Korea and internationally.
引用
- Lee H, Suh YH, Lee S, et al. Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017. Emerg Infect Dis. 2019. PMID: 30789143. doi:10.3201/eid2503.181503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。